In other words, we hypothesized that SS patients with Interferon-γ (IFN-γ)-inducible KP activation could develop chronic pain, depression, and low EGM disease activity, because the KP promotes an immunosuppressive and neurosensitive effect. This evidence concerns the gene IFNG and synovial sarcoma.